Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins is the birthplace of cancer genomics (Vogelstein), MSI-high immunotherapy (Le, Diaz), and liquid biopsy and MCED science (CancerSEEK).
Overview
Johns Hopkins Hospital and its Sidney Kimmel Comprehensive Cancer Center in Baltimore are where cancer genomics began with Vogelstein and Kinzler, and the centre holds NCI comprehensive designation and tenth place in the Newsweek/Statista oncology ranking. Its record includes pembrolizumab in mismatch-repair-deficient tumours, the first tumour-agnostic approval, led by Le and Diaz, the CancerSEEK liquid biopsy that fed Exact Sciences' multi-cancer early detection programme, and the Bloomberg-Kimmel Institute for Cancer Immunotherapy under Drew M. Pardoll and Elizabeth M. Jaffee. Nuclide links it to DELFI Diagnostics, to the DETECT-A, DYNAMIC and CheckMate 816 papers, and to pathways from epigenetic reprogramming to telomere maintenance. Whether blood-based early detection lowers harm as well as finding cancers is the question its own work posed. Programmes and people are listed below.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Johns Hopkins University, including child institutions. 3,313 works · 48,889 citations · 66% open access · 10% clinical trials · 3% reviews.
- Elizabeth M. Jaffee159 works
- Jin Peng He123 works
- Richard Andrew Burkhart87 works
- Elana Judith Fertig84 works
- Won Jin Ho83 works
- Michael J. Pishvaian81 works
- Mark M. Yarchoan80 works
- Laura DeLong Wood78 works
- Ralph H. Hruban77 works
- Julie Renee Brahmer76 works
- Cancer genomics
- MSI-H immunotherapy
- Liquid biopsy / MCED
- Bloomberg-Kimmel Immunotherapy
Similar pages
not linked directly; found by shared links- CompanyAlpha Tau Medical
Shares Pembrolizumab, Prostate cancer.
- InstitutionUCLA Jonsson Comprehensive Cancer Center
- IndicationNeuroendocrine and small-cell prostate cancer
Shares Pembrolizumab, Prostate cancer.